Newly acquired AI-based solution recognized for its success in combating drug diversion in healthcare facilities
Wolters Kluwer Health is proud to announce that following its acquisition...
Rapid growth and adoption of Xenium Analyzer demonstrates strength of company's innovation engine, broad commercial reach and operational scale
10x Genomics, Inc., a leader in...
The precision medicine technology is being used for patients with metastatic lung and bone tumors at City of Hope's Los Angeles location and could treat more...
Merck, known as MSD outside of the United States and Canada, announced the initiation of the company’s Phase 3 clinical program, CORALreef, for MK-0616,...
Kerecis® Shield™, the new fish-skin wound-treatment product family for private doctors’ clinics, has been approved by multiple leading Medicare Administrative Contractors (MACs). This means that...
